ORMP
Price
$2.23
Change
+$0.01 (+0.45%)
Updated
Sep 5 closing price
Capitalization
91.44M
69 days until earnings call
TLPPF
Price
$9.04
Change
-$0.18 (-1.95%)
Updated
Sep 5 closing price
Capitalization
3.02B
Interact to see
Advertisement

ORMP vs TLPPF

Header iconORMP vs TLPPF Comparison
Open Charts ORMP vs TLPPFBanner chart's image
Oramed Pharmaceuticals
Price$2.23
Change+$0.01 (+0.45%)
Volume$58.88K
Capitalization91.44M
Telix Pharmaceutical
Price$9.04
Change-$0.18 (-1.95%)
Volume$569
Capitalization3.02B
ORMP vs TLPPF Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. TLPPF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a StrongBuy and TLPPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ORMP: $2.23 vs. TLPPF: $9.04)
Brand notoriety: ORMP and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 83% vs. TLPPF: 7%
Market capitalization -- ORMP: $91.44M vs. TLPPF: $3.02B
ORMP [@Biotechnology] is valued at $91.44M. TLPPF’s [@Biotechnology] market capitalization is $3.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, ORMP is a better buy in the long-term than TLPPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 5 TA indicator(s) are bullish while TLPPF’s TA Score has 4 bullish TA indicator(s).

  • ORMP’s TA Score: 5 bullish, 3 bearish.
  • TLPPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than TLPPF.

Price Growth

ORMP (@Biotechnology) experienced а +1.36% price change this week, while TLPPF (@Biotechnology) price change was -8.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($3.02B) has a higher market cap than ORMP($91.4M). TLPPF has higher P/E ratio than ORMP: TLPPF (387.72) vs ORMP (20.91). ORMP YTD gains are higher at: -7.851 vs. TLPPF (-39.633). TLPPF has higher annual earnings (EBITDA): 92.5M vs. ORMP (-22.07M). TLPPF has more cash in the bank: 710M vs. ORMP (97.9M). ORMP has less debt than TLPPF: ORMP (912K) vs TLPPF (581M). TLPPF has higher revenues than ORMP: TLPPF (783M) vs ORMP (2M).
ORMPTLPPFORMP / TLPPF
Capitalization91.4M3.02B3%
EBITDA-22.07M92.5M-24%
Gain YTD-7.851-39.63320%
P/E Ratio20.91387.725%
Revenue2M783M0%
Total Cash97.9M710M14%
Total Debt912K581M0%
FUNDAMENTALS RATINGS
ORMP vs TLPPF: Fundamental Ratings
ORMP
TLPPF
OUTLOOK RATING
1..100
1656
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
10055
SMR RATING
1..100
9568
PRICE GROWTH RATING
1..100
5994
P/E GROWTH RATING
1..100
475
SEASONALITY SCORE
1..100
n/a14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (53) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPPF (93) in the null industry. This means that ORMP’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's Profit vs Risk Rating (55) in the null industry is somewhat better than the same rating for ORMP (100) in the Pharmaceuticals Other industry. This means that TLPPF’s stock grew somewhat faster than ORMP’s over the last 12 months.

TLPPF's SMR Rating (68) in the null industry is in the same range as ORMP (95) in the Pharmaceuticals Other industry. This means that TLPPF’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's Price Growth Rating (59) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPPF (94) in the null industry. This means that ORMP’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's P/E Growth Rating (5) in the null industry is somewhat better than the same rating for ORMP (47) in the Pharmaceuticals Other industry. This means that TLPPF’s stock grew somewhat faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTLPPF
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEGOX40.030.83
+2.12%
First Eagle Gold C
EIMGX33.070.05
+0.15%
Eaton Vance Tx-Mgd Small-Cap I
BRWBX26.48N/A
N/A
MFS Blended Research Growth Eq B
RPEBX69.33N/A
N/A
American Funds New Perspective R2E
JSVZX25.53N/A
N/A
JPMorgan Small Cap Value R2

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and VALN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.45%
VALN - ORMP
29%
Poorly correlated
-2.15%
FULC - ORMP
28%
Poorly correlated
+11.34%
BCAB - ORMP
28%
Poorly correlated
+7.54%
PRLD - ORMP
27%
Poorly correlated
+7.89%
SONN - ORMP
27%
Poorly correlated
-1.72%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and BDTX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-1.95%
BDTX - TLPPF
22%
Poorly correlated
+2.44%
ITOS - TLPPF
21%
Poorly correlated
N/A
RCUS - TLPPF
21%
Poorly correlated
+5.45%
ORMP - TLPPF
21%
Poorly correlated
+0.45%
ABOS - TLPPF
20%
Poorly correlated
+4.35%
More